Increasing MuSK Activity Delays Denervation and Improves Motor Function in ALS Mice

Cell Reports

Volumn 2, Issue 3, 2012, Pages 497-502

  Pérez García, María J ^a   Burden, Steven J ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN MUSK; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASSAY; CONTROLLED STUDY; ENZYME ACTIVITY; GENE; GENE EXPRESSION; HISTOPATHOLOGY; LOCOMOTION; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; MOUSE; MUSCLE DENERVATION; MUSCLE INNERVATION; MUSK GENE; NERVE ENDING; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SURVIVAL; SYMPTOM;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; BEHAVIOR, ANIMAL; HUMANS; MICE; MICE, TRANSGENIC; MOTOR ACTIVITY; MUTATION, MISSENSE; RECEPTOR PROTEIN-TYROSINE KINASES; SUPEROXIDE DISMUTASE;

MUS; MUS MUSCULUS;

EID: 84866910281     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2012.08.004     Document Type: Article

References (32)

1. Burden S.J. The formation of neuromuscular synapses. Genes Dev. 1998, 12:133-148.
2. Chen-Plotkin A.S., Lee V.M., Trojanowski J.Q. TAR DNA-binding protein 43 in neurodegenerative disease. Nat. Rev. Neurol. 2010, 6:211-220.
3. DeChiara T.M., Bowen D.C., Valenzuela D.M., Simmons M.V., Poueymirou W.T., Thomas S., Kinetz E., Compton D.L., Rojas E., Park J.S., et al. The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo. Cell 1996, 85:501-512.
4. Fischer L.R., Culver D.G., Tennant P., Davis A.A., Wang M., Castellano-Sanchez A., Khan J., Polak M.A., Glass J.D. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp. Neurol. 2004, 185:232-240.
5. Gautam M., Noakes P.G., Moscoso L., Rupp F., Scheller R.H., Merlie J.P., Sanes J.R. Defective neuromuscular synaptogenesis in agrin-deficient mutant mice. Cell 1996, 85:525-535.
6. Hesser B.A., Henschel O., Witzemann V. Synapse disassembly and formation of new synapses in postnatal muscle upon conditional inactivation of MuSK. Mol. Cell. Neurosci. 2006, 31:470-480.
7. Ilieva H., Polymenidou M., Cleveland D.W. Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J. Cell Biol. 2009, 187:761-772.
8. Kaja S., van de Ven R.C., van Dijk J.G., Verschuuren J.J., Arahata K., Frants R.R., Ferrari M.D., van den Maagdenberg A.M., Plomp J.J. Severely impaired neuromuscular synaptic transmission causes muscle weakness in the Cacna1a-mutant mouse rolling Nagoya. Eur. J. Neurosci. 2007, 25:2009-2020.
9. Kang S.H., Fukaya M., Yang J.K., Rothstein J.D., Bergles D.E. NG2+ CNS glial progenitors remain committed to the oligodendrocyte lineage in postnatal life and following neurodegeneration. Neuron 2010, 68:668-681.
10. Kim N., Burden S.J. MuSK controls where motor axons grow and form synapses. Nat. Neurosci. 2008, 11:19-27.
11. Kim N., Stiegler A.L., Cameron T.O., Hallock P.T., Gomez A.M., Huang J.H., Hubbard S.R., Dustin M.L., Burden S.J. Lrp4 is a receptor for Agrin and forms a complex with MuSK. Cell 2008, 135:334-342.
12. Kong X.C., Barzaghi P., Ruegg M.A. Inhibition of synapse assembly in mammalian muscle in vivo by RNA interference. EMBO Rep. 2004, 5:183-188.
13. Kostic V., Jackson-Lewis V., de Bilbao F., Dubois-Dauphin M., Przedborski S. Bcl-2: prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis. Science 1997, 277:559-562.
14. Kwiatkowski T.J., Bosco D.A., Leclerc A.L., Tamrazian E., Vanderburg C.R., Russ C., Davis A., Gilchrist J., Kasarskis E.J., Munsat T., et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 2009, 323:1205-1208.
15. Lin W., Burgess R.W., Dominguez B., Pfaff S.L., Sanes J.R., Lee K.F. Distinct roles of nerve and muscle in postsynaptic differentiation of the neuromuscular synapse. Nature 2001, 410:1057-1064.
16. Lin W., Dominguez B., Yang J., Aryal P., Brandon E.P., Gage F.H., Lee K.F. Neurotransmitter acetylcholine negatively regulates neuromuscular synapse formation by a Cdk5-dependent mechanism. Neuron 2005, 46:569-579.
17. Majounie E., Renton A.E., Mok K., Dopper E.G., Waite A., Rollinson S., Chiò A., Restagno G., Nicolaou N., Simon-Sanchez J., et al. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol. 2012, 11:323-330. Chromosome 9-ALS/FTD Consortium, French research network on FTLD/FTLD/ALSFrench research network on FTLD/FTLD/ALS, ITALSGEN ConsortiumITALSGEN Consortium.
18. Misgeld T., Kummer T.T., Lichtman J.W., Sanes J.R. Agrin promotes synaptic differentiation by counteracting an inhibitory effect of neurotransmitter. Proc. Natl. Acad. Sci. USA 2005, 102:11088-11093.
19. Pasinelli P., Brown R.H. Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat. Rev. Neurosci. 2006, 7:710-723.
20. Pun S., Santos A.F., Saxena S., Xu L., Caroni P. Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF. Nat. Neurosci. 2006, 9:408-419.
21. Renton A.E., Majounie E., Waite A., Simón-Sánchez J., Rollinson S., Gibbs J.R., Schymick J.C., Laaksovirta H., van Swieten J.C., Myllykangas L., et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 2011, 72:257-268. ITALSGEN Consortium.
22. Sagot Y., Dubois-Dauphin M., Tan S.A., de Bilbao F., Aebischer P., Martinou J.C., Kato A.C. Bcl-2 overexpression prevents motoneuron cell body loss but not axonal degeneration in a mouse model of a neurodegenerative disease. J. Neurosci. 1995, 15:7727-7733.
23. Sanes J.R., Lichtman J.W. Induction, assembly, maturation and maintenance of a postsynaptic apparatus. Nat. Rev. Neurosci. 2001, 2:791-805.
24. Schaefer A.M., Sanes J.R., Lichtman J.W. A compensatory subpopulation of motor neurons in a mouse model of amyotrophic lateral sclerosis. J. Comp. Neurol. 2005, 490:209-219.
25. Stiegler A.L., Burden S.J., Hubbard S.R. Crystal structure of the frizzled-like cysteine-rich domain of the receptor tyrosine kinase MuSK. J. Mol. Biol. 2009, 393:1-9.
26. Vance C., Rogelj B., Hortobágyi T., De Vos K.J., Nishimura A.L., Sreedharan J., Hu X., Smith B., Ruddy D., Wright P., et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 2009, 323:1208-1211.
27. Watty A., Neubauer G., Dreger M., Zimmer M., Wilm M., Burden S.J. The in vitro and in vivo phosphotyrosine map of activated MuSK. Proc. Natl. Acad. Sci. USA 2000, 97:4585-4590.
28. Weatherbee S.D., Anderson K.V., Niswander L.A. LDL-receptor-related protein 4 is crucial for formation of the neuromuscular junction. Development 2006, 133:4993-5000.
29. Xie M.H., Yuan J., Adams C., Gurney A. Direct demonstration of MuSK involvement in acetylcholine receptor clustering through identification of agonist ScFv. Nat. Biotechnol. 1997, 15:768-771.
30. Yumoto N., Kim N., Burden S.J. Lrp4 is a retrograde signal for presynaptic differentiation at neuromuscular synapses. Nature 2012, Published online August 1, 2012. 10.1038/nature11348.
31. Zhang B., Luo S., Wang Q., Suzuki T., Xiong W.C., Mei L. LRP4 serves as a coreceptor of agrin. Neuron 2008, 60:285-297.
32. Zhang W., Coldefy A.S., Hubbard S.R., Burden S.J. Agrin binds to the N-terminal region of Lrp4 protein and stimulates association between Lrp4 and the first immunoglobulin-like domain in muscle-specific kinase (MuSK). J. Biol. Chem. 2011, 286:40624-40630.